According to Zimmer Biomet's latest financial reports and stock price the company's current Operating Margin is 9.26%. At the end of 2022 the company had an Operating Margin of 5.81%.
Year | Operating Margin | Change |
---|---|---|
2022 | 5.81% | -20.45% |
2021 | 7.31% | -287.1% |
2020 | -3.91% | -134.42% |
2019 | 11.35% | -432.06% |
2018 | -3.42% | -155.75% |
2017 | 6.13% | 17.28% |
2016 | 5.23% | 2448.58% |
2015 | 0.21% | -98.98% |
2014 | 20.20% | -4.82% |
2013 | 21.22% | -4.16% |
2012 | 22.14% | 0.69% |
2011 | 21.99% | 7.88% |
2010 | 20.38% | -16.37% |
2009 | 24.37% | -10.46% |
2008 | 27.22% | -6.24% |
2007 | 29.03% | -13.19% |
2006 | 33.44% | 5.6% |
2005 | 31.67% | 29.06% |
2004 | 24.54% | 6.63% |
2003 | 23.01% | -18.78% |
2002 | 28.34% | 38.64% |
2001 | 20.44% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | 31.50% | 240.17% | ๐บ๐ธ USA |
Stryker Corporation SYK | 16.21% | 75.05% | ๐บ๐ธ USA |
Cooper Companies COO | 14.36% | 55.08% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | -26.89% | -390.39% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.